Equities

Kubota Pharmaceutical Holdings Co Ltd

4596:TYO

Kubota Pharmaceutical Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)64.00
  • Today's Change0.00 / 0.00%
  • Shares traded75.20k
  • 1 Year change-24.71%
  • Beta1.5641
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2,6593,5632,694
Total Receivables, Net2.795.1825
Total Inventory377.43--
Prepaid expenses40100188
Other current assets, total1305071,718
Total current assets2,8694,1824,625
Property, plant & equipment, net129204192
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets183415
Total assets3,0174,4204,833
LIABILITIES
Accounts payable354375
Accrued expenses727670
Notes payable/short-term debt000
Current portion long-term debt/capital leases563962
Other current liabilities, total120202335
Total current liabilities283361542
Total long term debt87109137
Total debt143149200
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities370470680
SHAREHOLDERS EQUITY
Common stock2,1412,0671,309
Additional paid-in capital27,63827,52726,755
Retained earnings (accumulated deficit)(25670)(24181)(22165)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1462)(1463)(1747)
Total equity2,6473,9504,153
Total liabilities & shareholders' equity3,0174,4204,833
Total common shares outstanding565546
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.